143 related articles for article (PubMed ID: 15673543)
1. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era.
Bauer A; Guzik P; Barthel P; Schneider R; Ulm K; Watanabe MA; Schmidt G
Eur Heart J; 2005 Apr; 26(8):755-61. PubMed ID: 15673543
[TBL] [Abstract][Full Text] [Related]
2. QRS duration and late mortality in unselected post-infarction patients of the revascularization era.
Bauer A; Watanabe MA; Barthel P; Schneider R; Ulm K; Schmidt G
Eur Heart J; 2006 Feb; 27(4):427-33. PubMed ID: 16338936
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification and survival in post myocardial infarction patients: a large prospective and multicenter study in Japan.
Ohno J; Watanabe E; Toyama J; Kawamura T; Ohno M; Kodama I
Int J Cardiol; 2004 Feb; 93(2-3):263-8. PubMed ID: 14975557
[TBL] [Abstract][Full Text] [Related]
4. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
[TBL] [Abstract][Full Text] [Related]
7. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty.
Høfsten DE; Wachtell K; Lund B; Mølgaard H; Egstrup K
Eur Heart J; 2007 Feb; 28(4):407-14. PubMed ID: 17227787
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of heart rate variability after acute myocardial infarction.
Balanescu S; Corlan AD; Dorobantu M; Gherasim L
Med Sci Monit; 2004 Jul; 10(7):CR307-15. PubMed ID: 15232505
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the prevalence of non-invasive risk markers of the sudden cardiac death in patients treated by thrombolysis and by percutaneous transluminal coronary angioplasty].
Krivan L; Kozák M; Sepsi M; Lokaj P; Honziková N; Spinar J
Cas Lek Cesk; 2005; 144(8):546-8; discussion 548-9. PubMed ID: 16173609
[TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
13. Predicting irreversible left ventricular dysfunction after acute myocardial infarction.
Frisch DR; Giedrimas E; Mohanavelu S; Shui A; Ho KK; Gibson CM; Josephson ME; Zimetbaum PJ
Am J Cardiol; 2009 May; 103(9):1206-9. PubMed ID: 19406260
[TBL] [Abstract][Full Text] [Related]
14. [Renal and cardiac functions as prognostic factors after revascularization for myocardial infarction].
Reibis R; Herbstleb J; Kamke W; Dissmann R; Wegscheider K; Völler H
Dtsch Med Wochenschr; 2007 Jun; 132(23):1259-63. PubMed ID: 17541867
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification after acute myocardial infarction by heart rate turbulence.
Barthel P; Schneider R; Bauer A; Ulm K; Schmitt C; Schömig A; Schmidt G
Circulation; 2003 Sep; 108(10):1221-6. PubMed ID: 12939209
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
18. The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial.
Eskola MJ; Holmvang L; Nikus KC; Sclarovsky S; Tilsted HH; Huhtala H; Niemelä KO; Clemmensen P
Eur Heart J; 2007 Dec; 28(24):2985-91. PubMed ID: 17932102
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years.
Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Chin Med J (Engl); 2006 Jul; 119(14):1151-6. PubMed ID: 16863605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
